15:59 May 29

Dishman Carbogen Amcis Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
194.70
-2.99 (-1.51%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Dishman Carbogen Amcis Ltd. Financials

Dishman Carbogen Amcis Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
194.70
-2.99 (-1.51%)
15:59 May 29
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

66/100
Affordable Valuation

Technical

48/100
Technically Neutral

Strength

12

Weakness

1

Opportunity

1

Threats

1

1.45 %

ROE %

0.81 %

ROA %

6.22

EPS

425.82

BVPS

3.32 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
2140.69 2412.92 2615.77 2711.5 2931.9
Operating Expenses +
1809.32 2080.72 2329.27 2242.56 2366.27
Raw Material
460.5 624.99 601.21 592.96 487.85
Increase Decrease in Cost
-13.08 -113.58 -4.02 -91.31 -79.06
Other Manufacturing Expense
9.87 23.6 11.41 22.94 0
Employee Cost
981.49 1035.27 1208.16 1293.57 1446.93
Miscellaneous Expenses
370.54 510.44 512.51 424.4 510.55
Operating Profit
331.37 332.2 286.5 468.94 565.63
Other Income
43.42 27.77 28.21 21.68 55.94
Depreciation
307.59 280.72 310.86 293.74 338.69
Interest
56.81 85.69 119.97 159.46 174.18
Profit before tax and exceptio..
10.39 -6.44 -116.12 37.42 108.7
Exceptional Items
-14.64 -48.15 -6.14 -18.11 -3.8
PBT
-4.25 -54.59 -122.26 19.31 104.9
Provision for Taxation
-22.26 -24.79 31.19 16.07 7.45
Net Profit
18.01 -29.8 -153.45 3.24 97.45
NET Profit after MI
18.01 -29.8 -153.45 3.24 97.45
EPS
1.15 -1.9 -9.79 0.21 6.22
Operating Profit Margin (%)
15.48 13.77 10.95 17.29 19.29
Net Profit Margin (%)
0.84 -1.24 -5.87 0.12 3.32

Dishman Carbogen Amcis Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 59.30 59.30 59.30 59.30 59.30 59.30
FII 7.40 7.70 8.10 9.90 9.50 8.80
Public 1.70 1.20 1.30 1.30 1.30 1.40
Others 31.60 31.80 31.30 29.50 29.90 30.50
Shareholder Shares Holding %
Download Our App On: